ENTITY
HK inno.N

HK inno.N (195940 KS)

20
Analysis
Health CareSouth Korea
HK inno.N Corp. develops and manufactures pharmaceuticals products. The Company develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products. HK inno.N conducts businesses across worldwide.
more
Refresh
bullishHK inno.N
23 May 2022 15:24

HK Inno. N (195940 KS): Flagship Drug K-CAB Is Set to Become a Global Blockbuster Drug

This year is the beginning for K-CAB to enter the global market. While the drug’s revenue jumped 71% y/y in Q1, its massive global expansion should...

Logo
403 Views
Share
bullishHK inno.N
03 Aug 2023 22:12

HK Inno.N (195940 KS): 2Q23 Result Shows Strong Sequential Improvement; K-CAB Continues to Fly High

In 2Q23, revenue increased 11% QoQ and operating profit grew 172% QoQ. K-CAB domestic revenue grew 19% QoQ. Flagship drug, K-CAB has been launched...

Logo
261 Views
Share
bearishCJ CGV Co Ltd
31 Jul 2023 13:46

End of Mandatory Lock-Up Periods for 40 Companies in Korea in August 2023

We discuss the end of the mandatory lock-up periods for 40 stocks in Korea in August 2023, among which 2 are in KOSPI and 38 are in KOSDAQ.

Logo
265 Views
Share
22 May 2022 17:54

Dr. Reddy's Laboratories (DRRD IN) 4QFY22: Double-Digit Sales Growth; One-Off Charge Impacted Profit

Dr. Reddy’s reported strong double-digit revenue growth in Q4, while one-off charges weighed on bottom-line. New product launches in the U.S....

Logo
266 Views
Share
23 Feb 2022 18:18

Ilyang Pharmaceutical (007570 KS): Key Drugs Facing Increasing Competition

Increasing competition for its key drugs, sequential decelerating financial performance in Q4, and recent institutional shareholder selling stocks...

Logo
604 Views
Share
x